| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10148596 | Epilepsy & Behavior | 2018 | 8 Pages |
Abstract
Patients with possible LGS have significantly higher healthcare utilization and costs than patients without epilepsy or seizures. Our results suggest that direct costs associated with LGS are substantial and highlight the need for new and effective treatments.
Keywords
AEDCPTCommercial insuranceTSCHCPCSPPPYLGSVNShealthcare resource utilizationCurrent Procedural Terminologyelectroencephalographicemergency departmentInpatientEpilepsyantiepileptic drugICDOutpatientLennox–Gastaut syndromeHealthcare Common Procedure Coding SystemInternational Classification of DiseasesMedicaidEEGDirect costsTuberous sclerosis complex
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Nancy L. Reaven, Susan E. Funk, Georgia D. Montouris, Timothy B. Saurer, Tyler J. Story,